Peripheral Nerve Stimulation for the Treatment of Chronic Intractable Headaches: Long-term Efficacy and Safety Study

被引:0
作者
Lee, Pyung B. [1 ]
Horazeck, Christian [2 ]
Nahm, Francis S. [1 ]
Huh, Billy K. [3 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Anesthesiol & Pain Med, Songnam, South Korea
[2] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pain Med, Houston, TX 77030 USA
关键词
Migraine headache; refractory headache; chronic daily headache; occipital neuralgia; cluster headache; hemicranias continua; occipital nerve stimulation; peripheral nerve stimulation; SPINAL-CORD STIMULATION; CHRONIC MIGRAINE; PAIN; NEUROSTIMULATION; MANAGEMENT; MECHANISMS; NEURALGIA;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Despite the various modalities available for treating headaches, typical therapy does not provide adequate pain relief for some patients. Objectives: This study explored the efficacy and safety of long-term peripheral nerve stimulation (PNS) for intractable chronic headaches. Study Design: Retrospective study of refractory headache patients at academic pain center. Methods: The medical records of all patients (N = 46) permanently implanted with PNS between January 2005 and January 2012 were reviewed retrospectively. Patient records and phone interviews were used to quantify the levels of pain intensity, headache days per month, and overall patient satisfaction with treatment. The correlation between headache duration and effectiveness of PNS was also assessed. Results: Pain intensity on the 11-point Numeric Rating Scale decreased from 7.60 +/- 1.73 before implantation to 3.78 +/- 2.41, 3.32 +/- 2.67, 3.42 +/- 2.74, and 2.04 +/- 2.27 at one, 6, 12, and > 12 (19 - 98) months after implantation, respectively (P < .001). The mean number of headache days per month decreased by about 14 days from the base line. No correlation (r = -.33) was found between the number of years the patients had suffered from headaches and the efficacy of treatment. Limitations: Due to the limitation of a retrospective study, the data collected via chart reviews and phone interviews are susceptible to selection and information biases. Conclusions: PNS is an effective modality in the long-term management of intractable chronic headaches. Despite long histories of chronic headaches, the majority of patients had significant reductions in pain scores and the number of headache days per month. The outcomes were not dependent on the number of years the patients had suffered from headaches before PNS treatment.
引用
收藏
页码:505 / 516
页数:12
相关论文
共 32 条
[1]   Peripheral nerve stimulator for the treatment of supraorbital neuralgia: a retrospective case series [J].
Amin, S. ;
Buvanendran, A. ;
Park, K-S ;
Kroin, J. S. ;
Moric, M. .
CEPHALALGIA, 2008, 28 (04) :355-359
[2]  
Burgher Abram H, 2007, Pain Pract, V7, P279, DOI 10.1111/j.1533-2500.2007.00142.x
[3]   Occipital nerve stimulator systems: review of complications and surgical techniques [J].
Falowski, Steven ;
Wang, Dajie ;
Sabesan, Arvind ;
Sharan, Ashwini .
NEUROMODULATION, 2010, 13 (02) :121-125
[4]   Towards a definition of intractable headache for use in clinical practice and trials [J].
Goadsby, P. J. ;
Schoenen, J. ;
Ferrari, M. D. ;
Silberstein, S. D. ;
Dodick, D. .
CEPHALALGIA, 2006, 26 (09) :1168-1170
[5]   Occipital nerve stimulation for headache: Mechanisms and efficacy [J].
Goadsby, Peter J. ;
Bartsch, Thorsten ;
Dodick, David W. .
HEADACHE, 2008, 48 (02) :313-318
[6]   Drug therapy: Migraine - Current understanding and treatment. [J].
Goadsby, PJ ;
Lipton, RB ;
Ferrari, MD .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :257-270
[7]   Burden of migraine in the United States -: Disability and economic costs [J].
Hu, XH ;
Markson, LE ;
Lipton, RB ;
Stewart, WF ;
Berger, ML .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (08) :813-818
[8]   Refractory migraine in a headache clinic population [J].
Irimia, Pablo ;
Palma, Jose-Alberto ;
Fernandez-Torron, Roberto ;
Martinez-Vila, Eduardo .
BMC NEUROLOGY, 2011, 11
[9]   Neurostimulation for Primary Headache Disorders: Part 2, Review of Central Neurostimulators for Primary Headache, Overall Therapeutic Efficacy, Safety, Cost, Patient Selection, and Future Research in Headache Neuromodulation [J].
Jenkins, Brian ;
Tepper, Stewart J. .
HEADACHE, 2011, 51 (09) :1408-1418
[10]   Epidemiology and comorbidity of headache [J].
Jensen, Rigmor ;
Stovner, Lars J. .
LANCET NEUROLOGY, 2008, 7 (04) :354-361